Unknown

Dataset Information

0

Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers.


ABSTRACT: The artemether-lumefantrine combination requires food intake for the optimal absorption of lumefantrine. In an attempt to enhance the bioavailability of lumefantrine, new solid dispersion formulations (SDF) were developed, and the pharmacokinetics of two SDF variants were assessed in a randomized, open-label, sequential two-part study in healthy volunteers. In part 1, the relative bioavailability of the two SDF variants was compared with that of the conventional formulation after administration of a single dose of 480 mg under fasted conditions in three parallel cohorts. In part 2, the pharmacokinetics of lumefantrine from both SDF variants were evaluated after a single dose of 480 mg under fed conditions and a single dose of 960 mg under fasted conditions. The bioavailability of lumefantrine from SDF variant 1 and variant 2 increased up to ?48-fold and ?24-fold, respectively, relative to that of the conventional formulation. Both variants demonstrated a positive food effect and a less than proportional increase in exposure between the 480-mg and 960-mg doses. Most adverse events (AEs) were mild to moderate in severity and not suspected to be related to the study drug. All five drug-related AEs occurred in subjects taking SDF variant 2. No clinically significant treatment-emergent changes in vital signs, electrocardiograms, or laboratory blood assessments were noted. The solid dispersion formulation enhances the lumefantrine bioavailability to a significant extent, and SDF variant 1 is superior to SDF variant 2.

SUBMITTER: Jain JP 

PROVIDER: S-EPMC5571342 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers.

Jain Jay Prakash JP   Leong F Joel FJ   Chen Lan L   Kalluri Sampath S   Koradia Vishal V   Stein Daniel S DS   Wolf Marie-Christine MC   Sunkara Gangadhar G   Kota Jagannath J  

Antimicrobial agents and chemotherapy 20170824 9


The artemether-lumefantrine combination requires food intake for the optimal absorption of lumefantrine. In an attempt to enhance the bioavailability of lumefantrine, new solid dispersion formulations (SDF) were developed, and the pharmacokinetics of two SDF variants were assessed in a randomized, open-label, sequential two-part study in healthy volunteers. In part 1, the relative bioavailability of the two SDF variants was compared with that of the conventional formulation after administration  ...[more]

Similar Datasets

| S-EPMC7187334 | biostudies-literature
| S-EPMC4302705 | biostudies-literature
| S-EPMC6636446 | biostudies-literature
| S-EPMC5771593 | biostudies-literature
| S-EPMC7318178 | biostudies-literature
| S-EPMC5903480 | biostudies-literature
| S-EPMC4346016 | biostudies-other
| S-EPMC7497692 | biostudies-literature
| S-EPMC7586835 | biostudies-literature
| S-EPMC3837847 | biostudies-other